These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31517289)

  • 1. Using zeta potential to study the ionisation behaviour of polymers employed in modified-release dosage forms and estimating their pK
    Barbosa JAC; Abdelsadig MSE; Conway BR; Merchant HA
    Int J Pharm X; 2019 Dec; 1():100024. PubMed ID: 31517289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release.
    Varum FJ; Merchant HA; Goyanes A; Assi P; Zboranová V; Basit AW
    Int J Pharm; 2014 Jul; 468(1-2):172-7. PubMed ID: 24727141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of a physiological pH 6.8 bicarbonate buffer system: application to the dissolution testing of enteric coated products.
    Liu F; Merchant HA; Kulkarni RP; Alkademi M; Basit AW
    Eur J Pharm Biopharm; 2011 May; 78(1):151-7. PubMed ID: 21255647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting the gastrointestinal behaviour of modified-release products: utility of a novel dynamic dissolution test apparatus involving the use of bicarbonate buffers.
    Merchant HA; Goyanes A; Parashar N; Basit AW
    Int J Pharm; 2014 Nov; 475(1-2):585-91. PubMed ID: 25195730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Achieving gastroresistance without coating: Formulation of capsule shells from enteric polymers.
    Barbosa JAC; Al-Kauraishi MM; Smith AM; Conway BR; Merchant HA
    Eur J Pharm Biopharm; 2019 Nov; 144():174-179. PubMed ID: 31541663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.
    Ibekwe VC; Fadda HM; Parsons GE; Basit AW
    Int J Pharm; 2006 Feb; 308(1-2):52-60. PubMed ID: 16356670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled release of acidic drugs in compendial and physiological hydrogen carbonate buffer from polymer blend-coated oral solid dosage forms.
    Wulff R; Rappen GM; Koziolek M; Garbacz G; Leopold CS
    Eur J Pharm Sci; 2015 Sep; 77():246-53. PubMed ID: 26093053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal release behaviour of modified-release drug products: dynamic dissolution testing of mesalazine formulations.
    Goyanes A; Hatton GB; Merchant HA; Basit AW
    Int J Pharm; 2015 Apr; 484(1-2):103-8. PubMed ID: 25721685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of a Single Experimental Design for the Optimization of Furosemide Modified-Release Tablet Formulations.
    Vlachou M; Siamidi A; Dotsikas Y
    Curr Drug Deliv; 2019; 16(10):931-939. PubMed ID: 31663479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro dissolution of proton-pump inhibitor products intended for paediatric and geriatric use in physiological bicarbonate buffer.
    Liu F; Shokrollahi H
    Int J Pharm; 2015 May; 485(1-2):152-9. PubMed ID: 25746736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward Biopredictive Dissolution for Enteric Coated Dosage Forms.
    Al-Gousous J; Amidon GL; Langguth P
    Mol Pharm; 2016 Jun; 13(6):1927-36. PubMed ID: 27139040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward Mechanistic Design of Surrogate Buffers for Dissolution Testing of pH-Dependent Drug Delivery Systems.
    Blechar JA; Al-Gousous J; Wilhelmy C; Postina AM; Getto M; Langguth P
    Pharmaceutics; 2020 Dec; 12(12):. PubMed ID: 33321933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications of Natural Polymeric Materials in Solid Oral Modified-Release Dosage Forms.
    Li L; Zhang X; Gu X; Mao S
    Curr Pharm Des; 2015; 21(40):5854-67. PubMed ID: 26446465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binders for colon specific drug delivery: an in vitro evaluation.
    Sinha VR; Kumria R
    Int J Pharm; 2002 Dec; 249(1-2):23-31. PubMed ID: 12433431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of the traditional Chinese medicine compound recipe heart-protecting musk pH-dependent gradient-release pellets.
    Song H; Guo T; Zhang R; Zheng C; Ma Y; Li X; Bi K; Tang X
    Drug Dev Ind Pharm; 2002 Nov; 28(10):1261-73. PubMed ID: 12476872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastro-resistant characteristics of GRAS-grade enteric coatings for pharmaceutical and nutraceutical products.
    Czarnocka JK; Alhnan MA
    Int J Pharm; 2015; 486(1-2):167-74. PubMed ID: 25796126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit S100:L100 dispersion.
    Bando H; McGinity JW
    Int J Pharm; 2006 Oct; 323(1-2):11-7. PubMed ID: 16815652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simulated, biorelevant, clinically relevant or physiologically relevant dissolution media: The hidden role of bicarbonate buffer.
    Amaral Silva D; Al-Gousous J; Davies NM; Bou Chacra N; Webster GK; Lipka E; Amidon G; Löbenberg R
    Eur J Pharm Biopharm; 2019 Sep; 142():8-19. PubMed ID: 31195131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel coating concept for ileo-colonic drug targeting: proof of concept in humans using scintigraphy.
    Varum FJ; Hatton GB; Freire AC; Basit AW
    Eur J Pharm Biopharm; 2013 Aug; 84(3):573-7. PubMed ID: 23348235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation Of drug release using Eudragit L100-55 and Eudragit S100 combinations.
    Khan MZ; Prebeg Z; Kurjaković N
    J Control Release; 1999 Mar; 58(2):215-22. PubMed ID: 10053194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.